InMed Pharmaceuticals Inc. (INM) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

InMed Pharmaceuticals Inc...

NASDAQ: INM · Real-Time Price · USD
2.29
0.03 (1.33%)
At close: Oct 03, 2025, 3:59 PM
2.28
-0.44%
Pre-market: Oct 06, 2025, 08:06 AM EDT

InMed Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is July - June.
Fiscal Year Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020
Cash & Equivalents
11.12M 4.68M 3.42M 5.58M 8.99M 10.31M 12.64M 9.13M 11.81M 12.99M 15.39M 12.82M 7.95M 7.37M 14.38M 19.44M 9.11M 11.88M 12.8M 4.5M
Short-Term Investments
43.56K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 57.74K n/a 57.6K 57.89K 57.3K 57.46K 57.49K 57.75K 43.16K
Long-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Assets
100.42K 100K 99.93K 100K 136.76K 135.7K 132.55K 137.85K 138.98K 199.48K 229.94K 234.59K 227.43K 135.72K 139.14K 10.93K 18.12K 18.41K 18.71K 13.99K
Receivables
467.05K 367.81K 262.39K 284.7K 482.55K 281.82K 494.24K 224.6K 344.97K 230.33K 109.7K 20.79K 113.34K 88.16K 64.11K 335.58K 14.74K 88.31K 197.72K 51.87K
Inventory
965.2K 813.97K 1.1M 1.22M 1.7M 1.62M 987.28K 1.53M 2.14M 1.8M 2.17M 2.44M 3.21M 1.77M 1.26M n/a n/a n/a n/a n/a
Other Current Assets
323.09K 548.45K 684.31K 192.09K 712.28K 1.44M 1.53M 349.33K 718.62K 998.52K 1.17M 57.74K 57.69K n/a n/a n/a n/a n/a n/a n/a
Total Current Assets
12.92M 6.41M 5.47M 7.28M 11.88M 13.66M 15.65M 11.23M 15.01M 16.02M 18.83M 15.82M 12.36M 10.93M 15.94M 20.24M 10.36M 13.69M 13.09M 5.12M
Property-Plant & Equipment
996.35K 1.11M 1.23M 1.34M 1.71M 1.86M 1.96M 832.92K 958.37K 1.02M 945.82K 1.1M 1.16M 1.25M 1.4M 386.38K 403.91K 437.04K 477.35K 384.53K
Goodwill & Intangibles
1.63M 1.66M 1.7M 1.74M 2.44M 2.47M 2.47M 2.58M 2.58M 2.69M 2.72M 2.83M 2.72M 7.03M 7.23M 1.31M 1.31M 1.36M 1.42M 1.09M
Total Long-Term Assets
2.72M 2.87M 3.03M 3.19M 4.29M 4.47M 4.57M 3.55M 3.68M 3.91M 3.9M 4.17M 4.11M 8.42M 8.77M 1.71M 1.74M 1.82M 1.91M 1.49M
Total Assets
15.65M 9.28M 8.5M 10.47M 16.17M 18.13M 20.22M 14.78M 18.69M 19.92M 22.73M 19.99M 16.46M 19.35M 24.7M 21.96M 12.1M 15.51M 15M 6.6M
Account Payables
371.69K 559.81K 574.18K 449K 856.4K 546.38K 406.2K 514.42K 720.91K 997.49K 1.04M 1.5M 1.5M 2.09M 2.18M 1.59M 958.63K 999.15K 1.19M 152.74K
Deferred Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 21.52K n/a 11.12K 10.69K n/a n/a n/a n/a n/a
Short-Term Debt
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 36.62K 74.72K n/a n/a n/a n/a n/a
Other Current Liabilities
546.01K 464.66K 337.01K 236.69K 667.78K 278.23K 597.63K 378.58K 739.85K 958.68K 542.46K 342.15K 179.13K 888.9K 570.58K 346.11K 1.09M 731.77K 705.68K 655.14K
Total Current Liabilities
1.85M 1.84M 1.79M 1.44M 2.7M 2.07M 2.23M 1.81M 2.65M 3.07M 3.23M 4.5M 4.27M 5.13M 5.89M 2.44M 2.74M 2.15M 2.75M 1.87M
Long-Term Debt
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 2.25M n/a
Total Long-Term Liabilities
307.03K 419.35K 528.89K 633.79K 881.94K 984.15K 1.06M n/a 21.19K 98.46K 247.1K 403.48K 501.51K 616.69K 762.96K 226.29K 234.1K 271.64K 2.56M 235.6K
Total Liabilities
2.15M 2.26M 2.32M 2.07M 3.58M 3.06M 3.29M 1.81M 2.67M 3.17M 3.47M 4.9M 4.78M 5.75M 6.65M 2.67M 2.97M 2.43M 5.31M 2.11M
Total Debt
744.37K 848.59K 948.32K 1.06M 1.32M 1.45M 1.55M 396.79K 518.92K 671.35K 803.78K 957.52K 1.02M 1.15M 1.34M 330.48K 333.64K 370.66K 402.61K 307K
Book Value
13.49M 7.02M 6.18M 8.4M 12.59M 15.07M 16.93M 12.97M 16.02M 16.75M 19.26M 15.09M 11.69M 13.6M 18.06M 19.29M 9.12M 13.08M 9.69M 4.49M
Book Value Per Share
13.82 6.41 8.74 13.54 14.12 15.68 21.76 38.97 49.57 50.34 83.73 174.53 181.54 240.30 325.98 400.46 283.47 433.27 397.80 215.20
Common Stock
91.6M 87.46M 84.48M 84.2M 113.22M 109.38M 105.96M 105.12M 102.83M 104.98M 100.59M 99.62M 91.06M 87.24M 88.06M 80.7M 74.93M 76.11M 74.07M 53.07M
Retained Earnings
-117.73M -115.45M -113.25M -110.75M -149.18M -145.39M -139.73M -140.75M -134.33M -136.69M -133.11M -132.92M -120.33M -106.93M -104.64M -98.61M -92.57M -89.94M -87.46M -66.25M
Comprehensive Income
129.11K 128.57K 128.48K 128.57K 175.83K 174.47K 170.42K 174.11K 170.32K 173.89K 172.75K 176.25K 165.54K 160.64K 163.86K 162.91K 159.01K 161.51K 164.17K -172.47K
Shareholders Equity
13.49M 7.02M 6.18M 8.4M 12.59M 15.07M 16.93M 12.97M 16.02M 16.75M 19.26M 15.09M 11.69M 13.6M 18.06M 19.29M 9.12M 13.08M 9.69M 4.49M
Total Investments
43.56K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 57.74K n/a 57.6K 57.89K 57.3K 57.46K 57.49K 57.75K 43.16K